hat
Sike ensidan ki jan de 2 maladi sik, dyabèt nan yon lane pwès kat ane pase diminye ak orlistat (6.2%) konpare ak fo medikaman (9.0%). Itilize yon tan ki long orlistat tou kondwi a yon modès sou zafè pou diminye nan tansyon (vle di rediksyon de 2.5 ak 1.9 mmHg nan artérielle ak diastolic tansyon respektivman).
eng
incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).